Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile
Amer Psychiatric Pub

@apa_publishing

American Psychiatric Association Publishing is the world's premier publisher of books, journals, and multimedia on psychiatry, and mental health

ID: 19400875

linkhttp://www.appi.org calendar_today23-01-2009 16:27:52

3,3K Tweet

10,10K Followers

612 Following

Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Since the first transcranial magnetic stimulation (TMS) system was cleared by the U.S. Food and Drug Administration in 2008 to treat major depressive disorder in adult patients, the field of TMS has experienced tremendous growth. bit.ly/49Kf6C5

Since the first transcranial magnetic stimulation (TMS) system was cleared by the U.S. Food and Drug Administration in 2008 to treat major depressive disorder in adult patients, the field of TMS has experienced tremendous growth.  bit.ly/49Kf6C5
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

COMING SOON: Since the 2009 publication of Cognitive-Behavior Therapy for Severe Mental Illness, practitioners and researchers around the world have built on its tenets to further advance care. bit.ly/3Z0fcRV

COMING SOON: Since the 2009 publication of Cognitive-Behavior Therapy for Severe Mental Illness, practitioners and researchers around the world have built on its tenets to further advance care. bit.ly/3Z0fcRV
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

The DSM-5-TR Casebook and Treatment Guide for Child Mental Health has a singular aim: to help clinicians navigate the complexities of diagnosing and treating mental disorders in children and adolescents. bit.ly/4jLJbpO

The DSM-5-TR Casebook and Treatment Guide for Child Mental Health has a singular aim: to help clinicians navigate the complexities of diagnosing and treating mental disorders in children and adolescents. bit.ly/4jLJbpO
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

The ultimate companion volume to DSM-5-TR, the Study Guide is designed to help clinical learners, teachers, and practitioners in psychiatry, psychology, and social work understand and apply diagnostic criteria. bit.ly/3ZHYOFf

The ultimate companion volume to DSM-5-TR, the Study Guide is designed to help clinical learners, teachers, and practitioners in psychiatry, psychology, and social work understand and apply diagnostic criteria. bit.ly/3ZHYOFf
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule is meticulously researched, engagingly written, and comprehensive in scope. bit.ly/4kI6QHj

Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule is meticulously researched, engagingly written, and comprehensive in scope. bit.ly/4kI6QHj
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

A seminal resource since the first edition was published in 1986, Schatzberg's Manual of Clinical Psychopharmacology has distinguished itself, from the very beginning, for its readability and comprehensive approach to the field. bit.ly/3H93vmd

A seminal resource since the first edition was published in 1986, Schatzberg's Manual of Clinical Psychopharmacology has distinguished itself, from the very beginning, for its readability and comprehensive approach to the field. bit.ly/3H93vmd
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

The National Institute of Mental Health estimates that more than 21% of U.S. adults will experience a mood disorder at some point in their lives and 31% will experience an anxiety disorder. bit.ly/3w2kSj5

The National Institute of Mental Health estimates that more than 21% of U.S. adults will experience a mood disorder at some point in their lives and 31% will experience an anxiety disorder. bit.ly/3w2kSj5
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

By 2050, 85.7 million people in the United States are projected to be 65 or older. Older adults are especially prone to the effects of substances, and a 2021 survey showed that 4 million older adults were dealing with a substance use disorder. bit.ly/3FqZitr

By 2050, 85.7 million people in the United States are projected to be 65 or older. Older adults are especially prone to the effects of substances, and a 2021 survey showed that 4 million older adults were dealing with a substance use disorder. bit.ly/3FqZitr
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Regardless of their familiarity with ASD, readers will find actionable insights and strategies in this guide that will help them provide immediate assistance to their patients and work collaboratively and effectively with families and other providers. bit.ly/4iQBWMr

Regardless of their familiarity with ASD, readers will find actionable insights and strategies in this guide that will help them provide immediate assistance to their patients and work collaboratively and effectively with families and other providers. bit.ly/4iQBWMr
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Integrating cutting-edge neuroscience and clinical research,this book is the first textbook in the field to provide an affirming and intersectional approach to caring for transgender, non-binary, and gender-expansive (TNG) people. bit.ly/3tc3Ayw @pennmedicine @penneidos

Integrating cutting-edge neuroscience and clinical research,this book is the first textbook in the field to provide an affirming and intersectional approach to caring for transgender, non-binary, and gender-expansive (TNG) people. bit.ly/3tc3Ayw 
@pennmedicine
@penneidos
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Since the first transcranial magnetic stimulation (TMS) system was cleared by the U.S. Food and Drug Administration in 2008 to treat major depressive disorder in adult patients, the field of TMS has experienced tremendous growth. bit.ly/49Kf6C5

Since the first transcranial magnetic stimulation (TMS) system was cleared by the U.S. Food and Drug Administration in 2008 to treat major depressive disorder in adult patients, the field of TMS has experienced tremendous growth.  bit.ly/49Kf6C5
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

With examinations of 19 new psychiatric drugs, 19 new forms of previously available drugs, and a host of new medical agents, this third edition of the Clinical Manual of Psychopharmacology in the Medically Ill has been updated to reflect current practices. bit.ly/3YTquWU

With examinations of 19 new psychiatric drugs, 19 new forms of previously available drugs, and a host of new medical agents, this third edition of the Clinical Manual of Psychopharmacology in the Medically Ill has been updated to reflect current practices. bit.ly/3YTquWU
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

The Pocket Guide to LGBTQ Mental Health is a down-to-earth, informative, and affirming manual for mental health clinicians working with patients of diverse gender and sexual identities. bit.ly/4mAluSq

The Pocket Guide to LGBTQ Mental Health is a down-to-earth, informative, and affirming manual for mental health clinicians working with patients of diverse gender and sexual identities. bit.ly/4mAluSq
American Psychiatric Association (@apapsychiatric) 's Twitter Profile Photo

Pride Month | Dr. Freeman was the 102nd President of the APA from 1973–1974. During his tenure, he supported gay-rights efforts to destigmatize homosexuality as a mental disorder. Learn more about LGBTQ+ Leaders in Psychiatry here: ow.ly/52kC50W15ej #Pride

Pride Month | Dr. Freeman was the 102nd President of the APA from 1973–1974. During his tenure, he supported gay-rights efforts to destigmatize homosexuality as a mental disorder.

Learn more about LGBTQ+ Leaders in Psychiatry here: 
ow.ly/52kC50W15ej #Pride
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Regardless of their familiarity with ASD, readers will find actionable insights and strategies in this guide that will help them provide immediate assistance to their patients and work collaboratively and effectively with families and other providers. bit.ly/4iQBWMr

Regardless of their familiarity with ASD, readers will find actionable insights and strategies in this guide that will help them provide immediate assistance to their patients and work collaboratively and effectively with families and other providers. bit.ly/4iQBWMr
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

The National Institute of Mental Health estimates that more than 21% of U.S. adults will experience a mood disorder at some point in their lives and 31% will experience an anxiety disorder. bit.ly/3w2kSj5

The National Institute of Mental Health estimates that more than 21% of U.S. adults will experience a mood disorder at some point in their lives and 31% will experience an anxiety disorder. bit.ly/3w2kSj5
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Given that second opinions identify additional treatment options in two-thirds of these cases, Encountering Treatment Resistance argues that it is time to move away from treatment resistance and toward pending remission. bit.ly/4l72qtD

Given that second opinions identify additional treatment options in two-thirds of these cases, Encountering Treatment Resistance argues that it is time to move away from treatment resistance and toward pending remission. bit.ly/4l72qtD
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Collected in a single volume for the first time, the writings in this novel anthology represent more than four decades of perspectives from the American Psychiatric Association's Solomon Carter Fuller Award lectures. bit.ly/45lALk8

Collected in a single volume for the first time, the writings in this novel anthology represent more than four decades of perspectives from the American Psychiatric Association's Solomon Carter Fuller Award lectures. bit.ly/45lALk8
Amer Psychiatric Pub (@apa_publishing) 's Twitter Profile Photo

Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule is meticulously researched, engagingly written, and comprehensive in scope. bit.ly/4kI6QHj

Ketamine: The Story of Modern Psychiatry's Most Fascinating Molecule is meticulously researched, engagingly written, and comprehensive in scope. bit.ly/4kI6QHj